Last update : 05/29/2014 | Version : 1 | ID : 60110
General | |
Identification | |
Detailed name | Contraception and recurrent venous event |
Sign or acronym | COREVE |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL |
General Aspects | |
Health determinants |
Addictions Occupation |
Others (details) | venous thrombosis |
Keywords | Evaluation, types of hormonal contraception, recurrence, impact, risk |
Scientific investigator(s) (Contact) | |
Name of the director | Scarabin |
Surname | Pierre-Yves |
Phone | + 33 (0)1 45 59 51 14 |
pierre-yves.scarabin@inserm.fr | |
Unit | INSERM U1018 CENTRE DE RECHERCHE EN ÉPIDÉMIOLOGIE ET SANTÉ DES POPULATIONS |
Organization | INSERM |
Collaborations | |
Funding | |
Funding status |
Mixed |
Details | INSERM, PIERRE FABRE MEDICAMENT |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | INSERM - Institut National de Santé et Recherche Médicale |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Cohort study |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Prospective Other bodies active in creating this cohort: PIERRE-YVES SCARABIN; GENEVIEVE PLU BUREAU; JACQUELINE CONARD; MARIE HELENE HORELLOU. |
Database objective | |
Main objective | General objective: to study whether or not different forms of hormonal contraception contribute to the risk of venous thrombosis recurrence for women at high risk of venous thromboembolism. |
Inclusion criteria | Women aged between 18 and 45 years attending Hôtel-Dieu de Paris Hospital for the first documented instance of a venous thrombotic event (Doppler ultrasound, computed tomography angiography scan, angiogram, etc.) and/or thrombophilia (factor V Leiden, prothrombin 20210a mutation, ATIII deficiency, PC, PS). |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) |
Population covered |
Sick population |
Gender |
Woman |
Geography area |
Local |
French regions covered by the database |
Île-de-France |
Detail of the geography area | Paris and surrounding region |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2010 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 2500 |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Declarative data Paraclinical data Biological data |
Clinical data (detail) |
Direct physical measures Medical registration |
Declarative data (detail) |
Paper self-questionnaire Face to face interview |
Paraclinical data (detail) | Medical Imaging |
Biological data (detail) | Type of samples collected: Systematic testing for thrombophilia as part of a specialist consultation. |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity Health event/mortality |
Procedures | |
Data collection method | Self-administered questionnaire: double data entry from paper questionnaire Interview: double data entry from paper questionnaire Clinical Examinations: handwritten with double data entry |
Participant monitoring |
Yes |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Data may be used by academic teams Data may be used by industrial teams |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05